New Retina Radio by Eyetube
The Art of Drug Choice: Phase 3 Trials in Wet AMD
32 min•19 november 2020
Om avsnittet
In episode 2 of the NRR miniseries “The Art of Drug Choice: Wet AMD and the Latest Data,” Dr. Khanani and roundtable participants Drs. Fuller, London, and Weng review the latest phase 3 efficacy data from the HAWK/HARRIER, ARCHWAY, and CEDAR/SEQUOIA studies. Also, Dr. Weng shares the case of a wet AMD patient whose response to therapy and toleration of treatment burden mandated a change in treatment. Could brolucizumab (Beovu, Novartis) be a solution?
This editorially independent podcast is supported with advertising.
Fler avsnitt
Visa alla avsnitt av New Retina Radio by EyetubeNew Retina Radio by Eyetube med Retina Today finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.